LERCANIDIPINA MYLAN 20mg film-coated tablets medication leaflet

C08CA13 lercanidipine • Cardiovascular system | Selective calcium channel blockers with mainly vascular effects | Dihydropyridine derivatives

Lercanidipine is a medication used for the treatment of high blood pressure (hypertension). It belongs to the class of calcium channel blockers in the dihydropyridine group and works by relaxing blood vessels, which reduces vascular resistance and lowers blood pressure.

Lercanidipine is taken orally, usually once daily, preferably at least 15 minutes before a meal, as fatty foods can affect its absorption. It is well-tolerated and has a long-lasting effect, making it suitable for long-term blood pressure control.

Common side effects include headache, dizziness, facial flushing, palpitations, or peripheral edema (swelling of the ankles). Rarely, allergic reactions or severe hypotension may occur. It is important to take lercanidipine as prescribed by a healthcare provider, and alcohol and grapefruit juice should be avoided, as they can enhance the effects of the medication.

General data about LERCANIDIPINA MYLAN 20mg

Substance: lercanidipine

Date of last drug list: 01-01-2021

Commercial code: W67167001

Concentration: 20mg

Pharmaceutical form: film-coated tablets

Quantity: 7

Product type: generic

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: MCDERMOTT LABORATORIES LTD. T/A GERARD LABORATORIE - IRLANDA

Holder: MYLAN IRELAND LIMITED - IRLANDA

Number: 10919/2018/01

Shelf life: 3 years

Concentrations available for lercanidipine

10mg, 20mg

Combinations with other substances